Form Bio has built an AI-powered cell and gene therapy platform to accelerate the development of safer and more effective therapies. The company's proprietary FORMsightAI platform uses machine learning models to design and optimize cell and gene therapy constructs and to predict their performance in vivo.  FORMsightAI reduces the time and cost of developing cell and gene therapies and aims to increase the likelihood of clinical success. The platform is used by Form Bio and its partners to develop a wide range of cell and gene therapies for diseases including cancer, rare diseases, and infectious diseases.

<p>Claim company profile to add description to this page.</p>


Form Bio

Founded: 2022
Location: Dallas, TX
Employee range: 11 - 50
Funding: $30M A Sep 2022
Investors: JAZZ Venture Partners

Short description:

Drug notes:

Long description:

Jobs: